ArticleInflammation2012

Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.

Wenchao Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.